- Home
- SAVA vs REE Comparison
SAVA vs REE Comparison
Compare SAVA & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- REE
- Stock Information
- Founded
- SAVA 1998
- REE 2011
- Country
- SAVA United States
- REE Israel
- Employees
- SAVA 30
- REE N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- REE Auto Manufacturing
- Sector
- SAVA Health Care
- REE Consumer Discretionary
- Exchange
- SAVA Nasdaq
- REE Nasdaq
- Market Cap
- SAVA 70.5M
- REE 70.5M
- IPO Year
- SAVA N/A
- REE N/A
- Fundamental
- Price
- SAVA $1.57
- REE $2.89
- Analyst Decision
- SAVA Buy
- REE Strong Buy
- Analyst Count
- SAVA 3
- REE 3
- Target Price
- SAVA $54.50
- REE $12.50
- AVG Volume (30 Days)
- SAVA 1.2M
- REE 178.1K
- Earning Date
- SAVA 05-09-2025
- REE 05-29-2025
- Dividend Yield
- SAVA N/A
- REE N/A
- EPS Growth
- SAVA N/A
- REE N/A
- EPS
- SAVA N/A
- REE N/A
- Revenue
- SAVA N/A
- REE $626,000.00
- Revenue This Year
- SAVA N/A
- REE N/A
- Revenue Next Year
- SAVA N/A
- REE $18,744.14
- P/E Ratio
- SAVA N/A
- REE N/A
- Revenue Growth
- SAVA N/A
- REE N/A
- 52 Week Low
- SAVA $1.15
- REE $2.31
- 52 Week High
- SAVA $42.20
- REE $11.72
- Technical
- Relative Strength Index (RSI)
- SAVA 45.15
- REE 40.06
- Support Level
- SAVA $1.37
- REE $2.60
- Resistance Level
- SAVA $1.73
- REE $2.97
- Average True Range (ATR)
- SAVA 0.13
- REE 0.30
- MACD
- SAVA 0.08
- REE 0.18
- Stochastic Oscillator
- SAVA 76.72
- REE 67.52
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.